These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24894391)

  • 21. The role of [18 F]FDOPA PET as an adjunct to conventional MRI in the diagnosis of aggressive glial lesions.
    Zinsz A; Pouget C; Rech F; Taillandier L; Blonski M; Amlal S; Imbert L; Zaragori T; Verger A
    Eur J Nucl Med Mol Imaging; 2024 Jul; 51(9):2672-2683. PubMed ID: 38637354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
    Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status of 18F-DOPA PET imaging in the detection of brain tumor recurrence.
    Calabria F; Cascini GL
    Hell J Nucl Med; 2015; 18(2):152-6. PubMed ID: 26187216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overall survival and progression-free survival in patients with primary brain tumors after treatment: is the outcome of [
    Chiaravalloti A; Esposito V; Ursini F; Di Giorgio E; Zinzi M; Calabria F; Cimini A; Schillaci O
    Ann Nucl Med; 2019 Jul; 33(7):471-480. PubMed ID: 30949937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular imaging of brain tumors with 18F-DOPA PET and PET/CT.
    Calabria F; Chiaravalloti A; Di Pietro B; Grasso C; Schillaci O
    Nucl Med Commun; 2012 Jun; 33(6):563-70. PubMed ID: 22395034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visual and semi-quantitative analysis of 6-[
    Suárez-Piñera M; Rodriguez-Bel L; Alemany M; Pons-Escoda A; Pudis M; Coello A; Reynes G; Vidal N; Cortes-Romera M; Macia M
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(1):6-13. PubMed ID: 37813239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 18F-FDOPA kinetics in brain tumors.
    Schiepers C; Chen W; Cloughesy T; Dahlbom M; Huang SC
    J Nucl Med; 2007 Oct; 48(10):1651-61. PubMed ID: 17873130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [PET scan and NMR spectroscopy for the differential diagnosis between brain radiation necrosis and tumour recurrence after stereotactic irradiation of brain metastases: Place in the decision tree].
    Menoux I; Noël G; Namer I; Antoni D
    Cancer Radiother; 2017 Aug; 21(5):389-397. PubMed ID: 28599998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas.
    Taïeb D; Tessonnier L; Sebag F; Niccoli-Sire P; Morange I; Colavolpe C; De Micco C; Barlier A; Palazzo FF; Henry JF; Mundler O
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):580-6. PubMed ID: 18394015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of PET [18F]FDOPA in Evaluating Low-grade Glioma.
    Villani V; Carapella CM; Chiaravalloti A; Terrenato I; Piludu F; Vidiri A; Schillaci O; Floris R; Marzi S; Fabi A; Pace A
    Anticancer Res; 2015 Sep; 35(9):5117-22. PubMed ID: 26254416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PET/CT using ¹⁸F-FDOPA provides improved staging of carcinoid tumor patients in a Canadian setting.
    Yakemchuk VN; Jager PL; Chirakal R; Reid R; Major P; Gulenchyn KY
    Nucl Med Commun; 2012 Mar; 33(3):322-30. PubMed ID: 22183015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation treatment planning in brain tumours: potential impact of 3-O-methyl-6-[(18)F]fluoro-L-DOPA and PET.
    Alheit H; Oehme L; Winkler C; Füchtner F; Hoepping A; Grabowski J; Kotzerke J; Beuthien-Baumann B
    Nuklearmedizin; 2008; 47(5):200-4. PubMed ID: 18852926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PET in differentiation of recurrent brain tumor from radiation injury.
    Langleben DD; Segall GM
    J Nucl Med; 2000 Nov; 41(11):1861-7. PubMed ID: 11079496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 18F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation.
    Imperiale A; Rust E; Gabriel S; Detour J; Goichot B; Duclos B; Kurtz JE; Bachellier P; Namer IJ; Taïeb D
    J Nucl Med; 2014 Mar; 55(3):367-72. PubMed ID: 24343986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of neuroblastic tumors using 18F-FDOPA PET.
    Lu MY; Liu YL; Chang HH; Jou ST; Yang YL; Lin KH; Lin DT; Lee YL; Lee H; Wu PY; Luo TY; Shen LH; Huang SF; Liao YF; Hsu WM; Tzen KY;
    J Nucl Med; 2013 Jan; 54(1):42-9. PubMed ID: 23213196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors affecting ¹⁸F FDOPA standardized uptake value in patients with primary brain tumors after treatment.
    Chiaravalloti A; Fiorentini A; Villani V; Carapella C; Pace A; Di Pietro B; Di Russo C; Palumbo B; Floris R; Schillaci O
    Nucl Med Biol; 2015 Apr; 42(4):355-9. PubMed ID: 25624151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
    Tripathi M; Sharma R; D'Souza M; Jaimini A; Panwar P; Varshney R; Datta A; Kumar N; Garg G; Singh D; Grover RK; Mishra AK; Mondal A
    Clin Nucl Med; 2009 Dec; 34(12):878-83. PubMed ID: 20139821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What effective technique to differentiate radiation brain necrosis from a tumor progression in patients treated with radiation: A monocentric retrospective study combining the MRI TRAMs technique and the (
    Lakehayli Z; Phlips P; Margoum A; Saoudi A; Hmaid L; Nejjar I; Oueslati H; Bourgois N; Dao S; Belkhir F
    Cancer Radiother; 2023 Jun; 27(4):273-280. PubMed ID: 37080856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas.
    Imani F; Agopian VG; Auerbach MS; Walter MA; Imani F; Benz MR; Dumont RA; Lai CK; Czernin JG; Yeh MW
    J Nucl Med; 2009 Apr; 50(4):513-9. PubMed ID: 19289420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The usefulness of dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET in the clinical evaluation of brain tumors in children and adolescents.
    Dunkl V; Cleff C; Stoffels G; Judov N; Sarikaya-Seiwert S; Law I; Bøgeskov L; Nysom K; Andersen SB; Steiger HJ; Fink GR; Reifenberger G; Shah NJ; Coenen HH; Langen KJ; Galldiks N
    J Nucl Med; 2015 Jan; 56(1):88-92. PubMed ID: 25525183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.